ReviewBiosensors2025
Recent Advances in the Detection of Aflatoxin M1 in Milk and Dairy Products.
Review in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- MOF-based fluorescent molecularly imprinted polymer nanosensor for the determination of aflatoxin M1 in water and cow milk with exceptional sensitivity.RSC advances · 2026Article
- AI-Assisted Electrochemical Immunosensing for Matrix-Aware Detection of Aflatoxin M1 and Atrazine in Food Matrices.Biosensors · 2026Article
- Fungal Contamination of Dairy Feed and Major Mycotoxin Transfer: A Risk Evaluation for Animal Exposure and Health.Toxins · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is an increasing demand to design user-friendly specific assays for the detection of analytes of interest for healthcare, environment, and agrifood. Modern biotechnology has approached this problem by using proteins, enzymes, or RNA/DNA fragments (aptamers) as biological recognition elements for biosensors/assays. The idea is to exploit the extremely wide range of selective affinities sculpted into the various proteins or aptamers by biological evolution. The number of compounds specifically recognized by different proteins and aptamers is very large and ranges from small molecules to macromolecules. The advantages of using proteins and aptamers as molecular recognition elements (MRE) for assays/biosensors are many, and involve relatively low costs in design and synthesis, water solubility, and finally high specificity. Many of the analytes of interest in the food control industry are relatively small. In this case, aptamers and antibodies are widely used as specific MREs in designing advanced biosensors. Aflatoxin B1 (AFB1) is the most frequently found aflatoxin in contaminated food samples, and is one of the most potent natural compounds in terms of genotoxicity and carcinogenicity. Aflatoxin M1 (AFM1) is the hydroxylated metabolite of AFB1 and is usually found in milk and milk products as a carry-over of AFB1 in animals that have ingested contaminated feed. AFM1 is also found in human milk, and has been shown to be hepatotoxic and carcinogenic. Here, we present recent advances in assays and biosensors based on the use of antibodies and aptamers as MREs that have been developed for monitoring the presence of AFM1 in milk and dairy products. The limitations and advantages of aptamer- and antibody-based assays/biosensors are discussed, as well as future research perspectives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.